Whereas Trypsin Acts Almost Exclusively on Peptide Bonds
Total Page:16
File Type:pdf, Size:1020Kb
884 BIOCHEMISTRY: WALSH AND NEURATH PROC. N. A. S. 22 Craig, L. G., W. Koenigsberg, and R. J. Hill, Amino Acids and Peptides with Antimetabolic Activity, CIBA Foundation Symposium (1958), p. 226. 23 Du Vigneaud, V., personal communication. 24 Mach, B., C. Slayman, and E. L. Tatum, manuscript in preparation. TRYPSINOGEN AND CHYMOTRYPSINOGEN AS HOMOLOGOUS PROTEINS BY KENNETH A. WALSH AND HANS NEURATH UNIVERSITY OF WASHINGTON, SEATFLE Communicated August 27, 1964 The striking similarity of many properties of trypsin and chymotrypsin has been well known for many years.1-5 Both enzymes originate in the acinar cells of pan- creatic tissue6 at identical rates7 as their inactive precursors trypsinogen and chymo- trypsinogen A, and both are activated by the cleavage (by trypsin) of the peptide bond contributed by the basic residue which is closest to the amino terminus of the zymogen.8, 9 Both enzymes catalyze the hydrolysis of peptide, amide, and ester bonds, and both are characterized by a high degree of selectivity toward the amino acids which donate carboxyl groups to these bonds.10-'2 In both cases, the enzymes appear to become acylated through these carboxyl groups as an intermediate step in the catalytic mechanism.."-"5 Both enzymes are inhibited by certain organic fluorophosphates such as DFP, 16 and the site of reaction of these inhibitors has been identified as a unique serine residue in the same tetrapeptide sequence.17' 18 The same serine residue becomes acylated as an intermediate in the catalytic mecha- nism."9 In addition to serine, a histidine residue has long been implicated as a componentof the active siteof both chymotrypsin and trypsin.20 Indirect supporting evidence, derived from the pH dependence of the acylation and deacylation steps, and from the effects of photooxidation on enzyme activation of chymotrypsin,2' has been recently strengthened and confirmed by the findings of Shaw and co- workers22-24 that bifunctional reagents, resembling in structure specific substrates, inactivate chymotrypsin and trypsin, respectively, by forming covalent derivatives of a single histidine residue in each enzyme. Chymotrypsinogen and trypsinogen resemble each other in certain chemical properties.1 These include molecular weights (approximately 25,000 and 24,000, respectively) and isoelectric points (approximately 9.3). A comparison of the amino acid compositions ofthe two zymogens25-27 in Table 1 revealsthat the similarity extends to this level also. The compositional similarity is made even more striking if certain residues of similar chemical character are grouped together, such as the total acidic, total basic, total aromatic, total branched hydrophobic, and total hydroxy-amino acid residues. Such comparative data are given at the bottom of Table 1. The only really striking difference between the two enzymes lies in their sub- strate specificity." Whereas trypsin acts almost exclusively on peptide bonds involving the carboxyl groups of lysine or arginine residues, chymotrypsin has no significant action upon these bonds, but is most active toward linkages involving the Downloaded by guest on September 29, 2021 VOL. 52, 1964 BIOCHEMISTRY: WALSH AND NEURATH 885 TABLE 1 AMINO ACID COMPOSITIONS OF TRYPSINOGEN26 AND CHYMOTRYPSINOGEN25 Trypsinogen Chymotrypsinogen Asparagine 16 14 Glutamine 11 10 Aspartic acid 10 9 Threonine 10 23 t Serine 33 29 Glutamic acid 3 5 Proline 9 9 Glycine 25 23 Alanine 14 22 Cystine/2 12 10 Valine 18 23 Methionine 2 2 Isoleucine 15 10 Leucine 14 19 Tyrosine 10 4 Phenylalanine 3 6 Tryptophan 4 8 Lysine 15 14 Histidine 3 2 Arginine 2 4 Total acidic residues 13 14 Lysine and arginine 17 18 Total amides 27 24 Total aromatic residues 17 18 Serine + threonine 43 52 Sum of isoleucine, leucine, and valine 47 52 carboxyl groups of aromatic amino acids. Althoughtrypsin also catalyzes the cleav- age of certain aromatic substrates (characteristic of chymotrypsin), it is less effec- tive than chymotrypsin in this regard, and far less effective than toward its own basic substrates. Several lines of evidence indicate that this property is intrinsic in trypsin itself, and not the result of a chymotryptic contamination.28 The recent finding of Mares-Guia and Shaw29 that a binding site for aromatic compounds ex- ists at the active center of trypsin indicates that the striking difference in specificity between the two enzymes may turn out to be a quantitative phenomenon, rather than a qualitative one, and draws attention again to the underlying similarity be- tween the two enzymes. The fundamental similarities in biological, mechanistic, and compositional char- acter between the two molecules have led to the logical prediction of an extensive similarity in primary structure,5 including in particular the regions of structure known to have functional importance. However, as the primary structure of the two molecules was evolved,30 no analogous amino acid sequences were found that were larger than the tetrapeptide sequence originally observed to surround the ser- ines of the active centers. More recently,3"-33 a nearly identical nonadecapeptide sequence was observed in chymotrypsin and trypsin containing two histidine resi- dues in sufficiently close proximity to each other to suggest that not one but both of them are functional components of the active center in both enzymes.26 The recent completion of the structure of chymotrypsinogen A25 and a tentative structure for trypsinogen27 31 permit a detailed comparison of the molecular struc- tures of the two enzymes, and a search for evidence of homology. This com- parison is made in Table 2 by outlining the linear structures of the two zymogens in such a fashion as to make in each the amino terminal isoleucine residue, formed Downloaded by guest on September 29, 2021 886 BIOCHEMISTRY: WALSH AND NEURATH PROC. N. A. S. TABLE 2 THE STRUCTURAL SIMILARITY OF TRYPSINOGEN AND CHYMOTRYPSINOGEN 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Chymotrypsinogen cys-gly-val-pro-ala-ile-gln-pro-val-leu-ser-gly-leu-ser-arg-ILE-VAL-GLY- Trypsinogen val-asp-asp-asp-asp-lys-ILE-VAL-GLY- 1 2 3 4 5 6 7 8 9 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 asp-glu-glu-ala-val-pro-gly-ser-trp-PRO-trp-GLN-VAL-SER-LEU-gln-asp-lys-thr-GLY-phe-HIS-PHE- gly-tyr-thr-cys-gly-ala-asn-thr-val-PRO-tyr-GLN-VAL-SER-LEU-asn- -ser-GLY-tyr-HIS-PHE_ 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 CYS-GLY-GLY-SER-LEU-ILE-ASN-glu-asn-TRP-VAL-VAL-thr-AIA-ALA-HIS-CYS-gly-val-thr-thr-ser-asp- CYS-GLY-GLY-SER-LEU-ILE-ASN-ser-gln-TRP-VAL-VAL-ser-AIA-ALA-HIS-CYS-tyr-lys-ser-gly-ile-gln- 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 VAL-val-val-ala-gly-glu-phe-asp-gln-gly-ser-ser-ser-glu-lys-ile-gln-lys-leu-lys-ile-ala-lys- VAL-arg-leu-gly-glu-asp-asn-ile-asn-val-val-glu-gly-asp-glu-gln-phe-ile-ser-ala-ser-lys-ser- 54 55, 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 val-phe-lys-asn-SER-lys-TYR-ASN-ser-leu-thr-ile-ASN-ASN-asn-ILE-thr-LEU-leu-LYS-LEU-ser-thr- ile-val-his-pro-SER- -TYR-ASN(pro,leuthr,asn)ASN-ASN-asp-ILE-met-LEL-ile-LYS-LEU-lys-ser- 77 78 79 80 81 82 83 84 85 86 87 88 89 go 91 92 93 94 95 96 97 98 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 AIA-ALA-SER-phe-ser-gln-thr-VAL-ser-ala-val-cys-LEU-PRO-ser-ala-ser-asp-asp-phe-ala-AIA-GLY- AIA-ALA-SER-leu-asn-ser-arg-VAL-ala-ser-ile-ser-LEU-PRO-thr-ser-cys- -41a-ser-AIA-GLY- 99 100 101 102 103 104 105 106 107 108 109 11o 111 112 113 114 115 116 117 118 119 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 THR-thr-CYS-val-thr-thr-GLY-TRP-GLY-leu-THR-arg-tyr-thr-asn-ala-asn-thr-PRO-ASP-arg-LEU-gln- THR-gln-CYS-leu-ile-ser-GLY-TRP-GLY-asn-THR-lys-ser-ser-gly-thr-ser-tyr-PRO-ASP-val-LEU-lys- 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 157 158 159 160 161 162 165 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 gln-ala-ser-leu-PRO-leu-LEU-SER-asn-thr-asn-CYS-LYS-lys-tyr-trp-gly-thr-lys-ILE-lys-asp-ala- cys-leu-lys-ala-PRO-ile-LEU-SER-asp-ser-ser-CYS-LYS-ser-ala-tyr-pro-gly-gln-ILE-thr-ser-asn- 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 MET-ile-CYS-AIA-GLY-ala-ser-gly-val-ser- -SER-CYS-met-GLY-ASP-SER-GLY-GLY-PRO-leu-VAIL.